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CATEGORIZATION OF RISK OF PROSTATE 
CANCER: PILOT TEST OF CLINICAL OUTCOMES 
AND RISK PERCEPTIONS
Bruner DW, Parlanti AA, Ross E, Raysor S, Mazzoni SE, 
Hanks GE
Fox Chase Cancer Center, Philadelphia, PA, USA
OBJECTIVES: To define clinically useful categories for
prostate cancer (PC) risk and associated outcomes.
Translating relative risk (RR) and cumulative risk (CR)
into risk categories is important if studies of PC epidemi-
ology and genetic predisposition are to have clinical util-
ity for education, counseling and decision-making. Indi-
vidual risk perceptions compared to clinical risk are
important for the study of behavioral outcomes. METH-
ODS: Risk categories were determined by an extensive
review of the literature. Using RR and CR for specific
risk factors, 4 categories were defined from low to very
high. The categories were then used to assess PC out-
comes in men at increased risk for PC (defined by race
and family history). Risk perceptions were assessed by
asking men to rate their chance of getting PC on a scale
from 0 to 100%. RESULTS: 264 men participated in this
study. Mean age was 47.7 years, and 52% were African
American, 48% were Caucasian. By nature of study eligi-
bility, only 3(1%) men were in the low risk category. Ac-
cording to study criteria, 54(20%) were in the moderate
risk, 129(49%) in the high risk, and 62(24%) in the very
high risk categories, 16(6%) were unknown. PC was di-
agnosed in 0 of the low and unknown, 7% of the moder-
ate, 5% of the high and 10% of the very high-risk
groups. Of the 62 men who answered the risk perception
item, there was no correlation between risk category and
risk perceptions. CONCLUSIONS: Lacking a Gail-like
model for PC risk, the search continues for quantifiable
risk categories with clinical utility. The extreme catego-
ries proposed in this pilot study show a trend toward
clinically meaningful categorization of PC risk. A meta-
analysis of RR and CR is underway to refine the catego-
ries. Risk categories and risk perceptions were not associ-
ated, as has been shown in breast cancer.
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CANCER PATIENTS AND ONCOLOGY NURSES 
ANCHOR ON WHEN USING THE EUROQOL 
DESCRIPTIVE SYSTEM IN MEASURING 
UTILITIES WITH THE STANDARD
GAMBLE TECHNIQUE?
Hauser R1,2, Koeller J1
1University of Texas at Austin, Austin, TX, USA; 2Abt 
Associates Clinical Trials, Cambridge, MA, USA
OBJECTIVE: To determine which of seven EuroQoL de-
scriptives used in collecting utility scores were the an-
chors for metastatic breast cancer patients (pts) and on-
cology nurses (nur). METHODS: Eight states of health
describing metastatic breast cancer were presented to 45
pts and 56 nur. Each health state had seven bullet points
describing varying degrees of severity in the following
categories: Mobility, Activities of Daily Living (ADL),
Hand/finger use (NOT EuroQoL), Usual Activity, Anxi-
ety/Depression, Ability to think (NOT EuroQoL), and
Pain/Discomfort. After the utility scores were obtained,
subjects were asked which of the seven variables were
most important and second most important to them.
RESULTS:
CONCLUSIONS: It appears that both pts and nur an-
chored mainly on the Self-Care variable. Combining the
most important with the next most important variable
demonstrates that the Anxiety/Depression variable was
also an important anchoring variable for both groups. Pts
appear to anchor more on Usual Activity than nur. Nur
appear to anchor more on Pain/Discomfort than pts. The
results also suggest that the Hand and Finger use variable
(NOT a EuroQoL variable) may not be necessary and
may actually overburden subjects. Overall, these finding
may help explain why metastatic breast cancer patients
differ from oncology nurses on utility scores.
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PREDICTORS OF CHEMOTHERAPY-RELATED 
NEUTROPENIA: A REVIEW OF THE
CLINICAL LITERATURE
Palmer C1, Brown R1, Wilson-Royalty M2, Lawless G2
1MEDTAP International Inc, Bethesda, MD, USA; 2Amgen, Inc, 
Thousand Oaks, CA, USA
OBJECTIVES: A literature review was conducted to
identify risk factors and predictors of chemotherapy-
related grade 3–4 and/or febrile neutropenia to assist
PATIENTS, N45
Most
Important
Variable,
N (%)
Next Most
Important
Variable,
N (%)
Row
Total,
N (%)
Mobility 11 (24.4) 3 (6.7) 14 (31.1)
ADL or Self Care 14 (31.1) 10 (22.2) 24 (53.3)
Hand or finger use 0 (0) 0 (0) 0 (0)
Usual Activity 3 (6.7) 7 (15.6) 10 (22.2)
Anxiety/Depression 9 (20.0) 11 (24.4) 20 (44.4)
Ability to Think 5 (11.1) 10 (22.2) 15 (33.3)
Pain/Discomfort 3 (6.7) 4 (8.9) 7 (15.6)
Column Total 45 (100%) 45 (100%)
NURSES, N56
Mobility 9 (16.1) 7 (12.5) 16 (28.6)
ADL or Self Care 18 (32.1) 14 (25.0) 32 (57.1)
Hand or finger use 0 (0) 0 (0) 0 (0)
Usual Activity 1 (1.8) 3 (5.4) 4 (7.2)
Anxiety/Depression 14 (25.0) 15 (26.8) 29 (51.8)
Ability to Think 4 (7.1) 9 (16.1) 13 (23.2)
Pain/Discomfort 10 (17.9) 8 (14.3) 18 (32.2)
Column Total 56 (100%) 56 (100.1% rounded)
